Influence of alcohol consumption on blood coagulation in rotational thromboelastometry (ROTEM): an in-vivo study

Article information

Korean J Anesthesiol. 2020;73(4):334-341
Publication date (electronic) : 2020 April 16
doi :
1Department of Anesthesiology and Intensive Care Medicine, Hannover Medical School, Hannover, Germany
2Institute of Legal Medicine, Hannover Medical School, Hannover, Germany
3Department of Gastroenterology, Hepatology and Endocrinology, Hannover Medical School, Hannover, Germany
4TWINCORE, Center for Experimental and Clinical Infection Research, Institute for Experimental Infection Research, Hannover, Germany
Corresponding author: Kai Johanning, M.D., D.E.S.A. Department of Anesthesiolgy and Intensive Care Medicine, Hannover Medical School, Carl-Neuberg-Straße 1, 30625 Hannover, Germany Tel: +49 176 1532 3319 Fax: +49 511 532 3642 Email:
*Hendrik Eismann and Lion Sieg contributed equally to this work.
Received 2020 February 12; Revised 2020 March 26; Accepted 2020 April 14.



Twenty-five to 85% of trauma patients are under the influence of alcohol in addition to experiencing injury-related coagulation impairment. Viscoelastic point-of-care tests (thrombelastography [TEG], rotational thromboelastometry [ROTEM]) are popular tools for rapid hemostasis assessment and therapeutic decision-making in this and other settings. While alcohol affects these tests in-vitro, their specific effects in-vivo are unclear. Therefore, we evaluated the effects of alcohol ingestion on ROTEM parameters.


Twenty volunteers provided informed consent to drinking red wine, whisk(e)y, or vodka to a target blood alcohol concentration of 1‰ within one hour, calculated with the Widmark formula. Blood samples were collected before drinking, at a breath alcohol concentration of 0.5‰, and at 1.0‰, but no later than one hour. After each blood collection, ExTEM and FibTEM tests were performed directly "at the bedside."


All participants had a blood alcohol concentration (BAC) of 0.00‰ at the beginning. The mean BACs at the second and third collection were 0.48 and 0.76‰, respectively. There were no significant differences in the ExTEM parameters. FibTEM measurements showed a significant difference at the A10 value (13.0 vs. 14.0 mm, P = 0.014) and a trend at the maximum amplitude (maximum clot firmness 13.7 vs. 16.2 mm, P = 0.075). We saw no significant differences in fibrinolysis parameters and no hyperfibrinolysis in our ROTEM measurements.


Ethanol ingestion can impair early fibrin polymerization. These results might be of special relevance in trauma and support routine application of ROTEM/TEG in such cases.


Trauma is notoriously associated with coagulopathy. Primarily, hemostatic impairment can be caused by the trauma itself, as described by Hess et al. [1] as "trauma-induced coagulopathy" (TIC). However, 25–85% of patients admitted to trauma centers are additionally intoxicated. In particular, vehicle accidents are often associated with alcohol consumption [2-5]. As alcohol alters coagulation, its effects might have far-reaching implications for trauma patients [6-8].

Previous studies showed multiple alterations in platelet function and prolonged bleeding time [9], inhibition of platelet adhesion to fibrinogen [10], impairment of fibrinolysis [11-13], slower rates of fibrin formation and fibrin cross-linking [3], and reduced fibrinogen and fibrin functionality [10,13]. A study found no effect on standard coagulation measures and no hemorrhagic complications [14]. Nonetheless, the precise in-vivo effects and temporal correlations of ethanol on hemostasis are still poorly understood.

While the prognostic relevance of ethanol levels in trauma remains unclear [15,16], the strong correlation between compromised blood coagulation and a worse outcome after trauma indicate the possible effects of ethanol consumption on clinical outcome [17,18]. Trauma mortality increases with blood ethanol level [19,20] and is associated with increased blood loss, resulting in a need for volume resuscitation and red blood cell transfusion [21]. Consequently, precise knowledge and specific treatment of hemostatic impairment caused by ethanol may be crucial.

Conventional coagulation tests are restricted to certain stages and components of the clotting process and, thus, neglect clot characteristics and possible hyperfibrinolysis. Hence, many trauma centers routinely apply viscoelastic point-of-care tests such as rotational thromboelastometry (ROTEM) for a more detailed hemostatic evaluation, as it reliably differentiates platelet or fibrinogen dysfunctions and also detects hyperfibrinolysis.

In a ROTEM based in-vitro study, Engström et al. [11] demonstrated a prolonged clot formation time (CFT) of 34% at an ethanol concentration of 1‰. At an ethanol concentration of 4‰, they found a prolonged CFT of about 118% as well as significantly reduced fibrinolysis.

We, therefore, examined the possible in-vivo hemostatic effects of ethanol through ROTEM in non-traumatized healthy volunteers.

Materials and Methods

This study was reviewed and approved by the local ethics committee at Hannover Medical School (No. 2066-2013).


We used the results from Engström et al. to calculate the required sample size. Based on the reported change in CFT of about 34% at an ethanol concentration of 1 ‰, a power of 80%, and a significance level of 0.05, 19 patients were required for sufficient evaluation.

All volunteer participants were employees of the “Department of Anaesthesiology and Intensive Care Medicine” at Hannover Medical School who provided informed consent at least one day before our study. The participants were physically and mentally healthy at the time of the study and had consumed no alcohol for seven days and reported no other oral ingestion for a minimum of six hours before the study. Furthermore, the participants had no intake of any long-term or any other kind of medication for seven days. The study took place at the department’s Christmas party. Our point-of-care setup is shown in Fig. 1. The study outline is depicted in Fig. 2.

Fig. 1.

Point-of-care setup for our study at the department’s Christmas party.

Fig. 2.

Flow-chart of the study design. ROTEM: rotational thromboelastometry, BAC: blood alcohol concentration, BrAC: breath alcohol concentration.

Calculated alcohol intake

The target blood alcohol concentration was 1‰. Individually required alcohol amounts were calculated according to the Widmark formula [22]. For a study period of one hour, we calculated alcohol depletion in g as "1 hour × body weight in kg / 10." The formulas "alcohol in g = (body weight in kg × 0.6 × 1.0‰) – 1 hour × body weight in kg / 10" and "alcohol in g = (body weight in kg × 0.7 × 1.0‰) - 1 hour × body weight in kg / 10" were used for female or male volunteers, respectively.

The participants were requested to drink the calculated amounts of alcohol within one hour. Alcoholic drinks (whisk[e]y, vodka, red wine) were selected according to individual preferences; the amounts were adjusted to the respective ethanol concentrations.

Blood sampling

Three blood samples were taken from a cubital vein. Butterfly cannulas (Safety-Multifly-Set®, Sarstedt, Inc., Germany) and several test tubes (S-Monovette® and Citrat-Monovette®, Sarstedt, Inc., Germany) were used. The first milliliter of blood drawn was discarded before each sampling.

The first sample was taken as a baseline measurement before ethanol ingestion. The second sampling was conducted when the breath alcohol concentration was approximately 0.5‰. The third blood collection was performed when the breath alcohol concentration was approximately 1.0‰ but not more than one hour after the initial alcohol ingestion. We assumed a maximum blood alcohol concentration one hour after ingestion with no further increase in blood alcohol concentration over time. The findings reported by Mitchell et al. [23] support our assumption. Each volunteer served as his/her own control.

Breath alcohol concentration (BrAC)

BrAC was measured in this study with an AlcoMed 3011 breath alcohol testing device (Envitec-Wismar GmbH, Germany). The device was calibrated and serviced 14 days before the study by authorized personnel. For measurement, the volunteer blew into the device with sufficient pressure, evenly and without interruption, until the device sounded a continuous tone. The result was presented in ‰ BrAC.

Samples were taken after the volunteer had abstained from smoking for at least five minutes and rinsed his/her mouth with water. The volunteers were instructed to breathe normally for at least two minutes before sampling. The mouthpieces were replaced for each measurement.


ROTEM (TEM International GmbH, Munich, Germany) (we used the ROTEM delta system) is a viscoelastic coagulation-testing device that has been described elsewhere in detail [24]. The "ExTem" and "FibTem" ROTEM measurements were initiated without delay after blood withdrawals.

Blood alcohol concentration (BAC)

The Department of Forensic Medicine at the Hannover Medical School measured the BAC.

Headspace gas chromatography was used for serum ethanol concentration analysis. Chromatographic separation was performed on a CBK-B 60/80, 1 m × 2.0 mm (Restek GmbH, Germany) column on a Clarus 480 gas chromatograph and a Turbo matrix 110 headspace sampler (Perkin Elmer, Inc., USA).

Testing for the presence and subsequent quantification of ethanol in blood was carried out in static headspace mode. All samples were prepared and injected in duplicate. Linear regression analysis was used to generate calibration curves with duplicate measurements of aqueous calibration standards (0.5, 1.0, 2.0, 3.0, 4.0, and 5.0 mg/L). The limit of quantification was 0.1 mg/L. The intra-day precision (expressed as percent relative standard deviation [%RSD]) and the accuracy (expressed as % bias) of the method were 5% and 7%, respectively. Serum ethanol concentrations were converted into BAC as usual for forensic blood ethanol analysis [25,26].


Demographic data included age, sex, weight, and height. The event data were the drinking start and end times, drink amounts and types, and BACs. Ethanol intake was calculated from the ingested beverages as described above.

Data were exported to IBM SPSS Statistics for Windows, version 22.0 (IBM Corp., USA) for further descriptive and explorative data analysis. We applied Wilcoxon tests to compare ROTEM data. P values < 0.05 were considered statistically significant. For multiple comparisons, P values were calculated using the Holm–Bonferroni method.


We examined a total of 20 healthy volunteers comprising eleven men (55%) and nine women (45%). Their mean age was 29.4 ± 6.0 years and their mean height and weight were 177.5 ± 8.6 cm and 77.7 ± 16.5 kg, respectively. The resulting mean body mass index (BMI) was 24.6 ± 4.2 kg/m². The basic participant data are summarized in Table 1. Each participant could choose between three types of alcohol: 10% chose red wine, 30% chose whisk(e)y, and 60% chose vodka. The volunteers consumed a mean of 51.29 ± 13.51 g ethanol each. The first blood withdrawal before ethanol consumption showed a BAC of 0.00 ± 0.0‰ for all participants. The mean BACs were 0.48 ± 0.3‰ and 0.76 ± 0.2‰ for the second and third blood samples, respectively. The detailed results of our ROTEM (ExTEM and FibTEM) analysis of the blood samples are shown in Table 2. We focused on the ExTEM and FibTEM clotting time (eCT), clot amplitudes after ten minutes (eA10/fA10), maximum clot firmness (eMCF/fMCF), and maximum lysis (eML/fML). The mean eCT baseline value was 61.4 ± 7.9 s. At the one-hour blood collection, the eCT was 60.2 ± 9.5 s. The A10 value indicates the amplitude of the ROTEM trace 10 minutes after the start of clotting. The eA10 and fA10 values were 56.4 ± 6.2 and 14.0 ± 4.8 mm, respectively. After consumption of the whole volume of ethanol, the eA10 and fA10 values were 55.7 ± 6.5 and 13.0 ± 4.2 mm, respectively. The mean eMCF was 62.9 ± 5.6 mm in the first blood sample and 62.1 ± 6.0 mm in the last sample. Regarding FibTEM, the fMCF was 16.2 ± 8.7 mm at baseline and 13.7 ± 4.9 mm at one hour. We saw no hyperfibrinolysis in the 60 ROTEM measurements, which we assumed to indicate a maximum lysis (ML) > 15%. Furthermore, we saw no significant difference in any fibrinolysis parameter. Comparisons of ROTEM parameters revealed no significant differences.

Basic Patient Data and Ethanol Ingestion

Blood Alcohol Concentrations and Rotational Thromboelastometry Parameters (n = 20)

Sex aspects

Our study included 9 female and 11 male participants. Our subgroup analysis divided by sex showed no significant differences in the measured ROTEM parameters in the female subgroup (Table 3). The male subgroup showed a significant difference in fA10 FibTEM value (P = 0.042, Table 3 and Fig. 3). We observed no significant differences in age, height, weight, and BMI. The female volunteers had to drink significantly less ethanol to reach the 1‰ target (P = 0.001) and had a significantly lower mean BAC than that in the male participants after the one-hour period (0.62 ± 0.2‰ vs. 0.87 ± 0.2‰, P = 0.004).

Sex Aspects

Fig. 3.

Rotational thromboelastometry parameters in male. eCT: ExTEM clotting time, eA10: ExTEM amplitude 10 minutes after clotting started, eMCF: ExTEM maximum clot firmness, eCFT: ExTEM clot formation time, fCT: FibTEM clotting time, fA10: FibTEM amplitude 10 minutes after clotting started, fMCF: FibTEM maximum clot firmness. *P < 0.05, differences between baseline and 1 h.


This study determined the in-vivo effect of alcohol consumption on coagulation measured by ROTEM. In our healthy participants, we observed a significant change in the fA10 value for early fibrin-clot (FibTEM). The other parameters were not significantly influenced by alcohol intake.

The reduced fA10 amplitude combined with a lower fMCF suggested that a moderate level of about 0.8‰ blood alcohol can affect fibrinogen polymerization. This finding is in line with the results of previous studies reporting fibrinolysis impairment [11-13], reduced fibrin formation and fibrin cross-linking rates [3], and reduced fibrinogen and fibrin functionality [10,13]. In a ROTEM-based study of more than 400 trauma patients, Howard et al. [27] showed a bidirectional effect on coagulation related to ethanol ingestion. They demonstrated an initially impaired clot formation and a subsequent inhibition of fibrinolysis. They assumed these balancing mechanisms made a supposed correlation of altered ROTEM measurements and outcome in ethanol intoxicated trauma patients very difficult. However, we did not observe impaired fibrinolysis in our healthy volunteers. The underlying mechanisms appear to be specific to the condition of severe trauma in combination with ethanol ingestion.

We observed a significant difference in the fA10 value in our male subgroup but not in the female subgroup. Spoerke et. al. [3] reported that sex was an independent factor impacting the coagulation system and the influence of ethanol on hemostasis. They found a significantly decreased clot formation speed and reduced cross-linking of fibrin after alcohol ingestion in healthy male volunteers. Generally, the outcome after severe trauma differs between men and women [28,29]. However, in our study, the male participants had significantly higher BAC after one hour than that in the female volunteers.

De Lange et al. [10] reported inhibition of platelet adhesion to fibrinogen after intake of alcohol in alcopops (Barcardi Breezer) but not red wine (Rioja). Thus, the alcohol type can affect coagulation alterations, particularly fibrin polymerization. Unfortunately, in our study, only two participants (10%) chose red wine. Therefore, a comparison of different kinds of alcohol to red wine was not possible.

We were unable to fully reproduce Engström’s in-vitro results in our in-vivo approach, as they showed strong disturbances of overall clot formation. CFT, which indicates the dynamics of clot formation, was reduced by 34% at an ethanol concentration of 1‰, and by 118% at 4‰, respectively [11]. Moreover, they observed reduced fibrinolysis. In our study, neither the dynamic parameters nor fibrinolysis differed after alcohol intake. All participants consumed a calculated amount of ethanol to reach a 1‰ BAC. For obvious reasons, for the in vivo setting, we did not take the 2 or 4‰ conditions into account. With a mean BAC of 0.76‰, we did not reach the calculated and targeted 1‰ within one hour. Engström and colleagues used 96% pure ethanol added directly to a test tube, obviously without any additives. This and different metabolites of ingested ethanol such as acetaldehyde may impair the assays differently [30]; furthermore, we allowed different types of alcohol (red wine, whisk[e]y and vodka). Moreover, we used citrated blood sample tubes. Naturally, Engtröms et al. established no correlation to the in-vivo situation due to the limitations of the in-vitro setting.

Based on our results, the implications for daily clinical practice remain unclear. Although the absolute reduction in fibrin clot firmness was only 1 mm at fA10 and 3 mm at fMCF, in patients with underlying coagulopathy (e.g., trauma patients), additionally impaired coagulation due to alcohol might affect bleeding, clinical outcome, and clinical therapeutic decisions.

Alcohol is a socially accepted and commonly used drug. Moderate amounts are even considered to be protective of the cardiovascular system [31,32]. The impact of acute ethanol intake on coagulation and the parameters of coagulation still require elucidation and are hotly debated. Some studies found no effect, particularly with regard to standard coagulation measurements and hemorrhagic complications [14]. Others described multiple effects of ethanol on the coagulation system such as alterations in platelet function and prolonged bleeding time [9] or inhibition of platelet adhesion to fibrinogen [10]. Point-of-care coagulation assessment by ROTEM or TEG has become a routine option in the last decade as it is considered to be a better predictor of clinical bleeding tendency than other coagulation tests [33,34]. Furthermore, it appears to be more sensitive and specific than routine coagulation tests in detecting impairments of the coagulation system [34-37]. ROTEM/TEG analysis evaluates hemostasis more holistically than the standard coagulation test. These tests allow the detection of whole clot formation, fibrinogen-platelet interactions, and hyperfibrinolysis [24].

A trial investigating hemostasis in 264 trauma patients with elevated ethanol blood concentration reported impaired clot formation in TEG assays; however, the elevated blood concentration was not predictive for transfusion requirements or early or late mortality. The authors concluded that ethanol potentially directly affected the TEG measurements and that further studies were needed [38].

Nevertheless, a significant number of patients in the emergency department are under the influence of higher BACs [25]. Trauma mortality increases with blood ethanol level [19,20] and trauma combined with ethanol is associated with increased blood loss requiring volume resuscitation and red blood cell transfusion [21]. Massive hemorrhage is one of the leading causes of death in trauma patients, accounting for approximately 40% of trauma deaths [39]. Furthermore, the trauma itself can cause a hemostasis imbalance known as TIC [40], which may lead to increased bleeding if alcohol intoxication is an additional factor. TIC is a complex mechanism triggered by hypoperfusion and activated protein C that eventually leads to hypofibrinogenemia, hyperfibrinolysis, impaired fibrinogen polymerization, and subsequent inhibition of normal clot formation, especially in cases of extensive tissue trauma [41,42]. Extrapolating our results, it could be presumed that alcohol might aggravate hemostasis impairment. One conceivable mechanism besides the direct impairment of fibrinogen polymerization is that alcohol-positive trauma patients had elevated base excess levels compared to trauma patients without alcohol with comparable severities of injury [38]. Hess et al. [1] described the coagulopathy of trauma as a situation in which acidemia itself impairs plasma protease function and coagulation factor complex activity. Ethanol or its metabolites may aggravate acidemia and, therefore, contribute to the alteration of coagulation.

This study has several limitations: we did not reach the average blood alcohol target of 1‰ in every volunteer, which limits the comparability of our data. Moreover, the type of alcohol was freely selectable. Because of this, the discrimination of specific type-dependent alcohol effects was complicated. Furthermore, the sample size was not powered to show specific sex effects. In addition, all participants were healthy.

In conclusion, our results showed a moderate impairment of thrombelastometric measurements, limited to early fibrin clot formation, in healthy volunteers. However, the fibrin-clot, determined by thrombelastometric methods, is expected to diminish after usual alcohol intake with the potential risk of falling below critical levels if other coagulation impairments supervene. Further studies are needed to evaluate the influence of ethanol itself on thromboelastometry and to determine the effects of acute ethanol intoxication on hemostasis, particularly in trauma patients.


Conflicts of Interest

No potential conflict of interest relevant to this article was reported.

Author Contributions

Hendrik Eismann (Conceptualization; Data curation; Formal analysis; Investigation; Methodology; Writing – original draft; Writing – review & editing)

Lion Sieg (Conceptualization; Data curation; Formal analysis; Investigation; Methodology; Visualization; Writing – original draft; Writing – review & editing)

Hala Ahmed (Data curation; Investigation; Writing – review & editing)

Joerg Teske (Formal analysis; Investigation; Writing – review & editing)

Patrick Behrendt (Formal analysis; Writing – review & editing)

Lars Friedrich (Data curation; Writing – review & editing)

Carsten Schumacher (Data curation; Investigation; Writing – review & editing)

Kai Johanning (Conceptualization; Data curation; Investigation; Methodology; Writing – original draft; Writing – review & editing)


1. Hess JR, Brohi K, Dutton RP, Hauser CJ, Holcomb JB, Kluger Y, et al. The coagulopathy of trauma: a review of mechanisms. J Trauma 2008;65:748–54.
2. Maier RV. Ethanol abuse and the trauma patient. Surg Infect (Larchmt) 2001;2:133–41.
3. Spoerke N, Underwood S, Differding J, Van P, Sambasivan C, Shapiro D, et al. Effects of ethanol intoxication and gender on blood coagulation. J Trauma 2010;68:1106–11.
4. McAnally HM, Kypri K. Alcohol and road safety behaviour among New Zealand tertiary students. Int J Adolesc Med Health 2004;16:229–37.
5. Singleton M, Qin H, Luan J. Factors associated with higher levels of injury severity in occupants of motor vehicles that were severely damaged in traffic crashes in Kentucky, 2000-2001. Traffic Inj Prev 2004;5:144–50.
6. Olsen H, Osterud B. Effects of ethanol on human blood fibrinolysis and coagulation. Alcohol Alcohol Suppl 1986;1:591–4.
7. Lacoste L, Hung J, Lam JY. Acute and delayed antithrombotic effects of alcohol in humans. Am J Cardiol 2001;87:82–5.
8. Serebruany VL, Lowry DR, Fuzailov SY, Levine DJ, O'Connor CM, Gurbel PA. Moderate alcohol consumption is associated with decreased platelet activity in patients presenting with acute myocardial infarction. J Thromb Thrombolysis 2000;9:229–34.
9. Haut MJ, Cowan DH. The effect of ethanol on hemostatic properties of human blood platelets. Am J Med 1973;56:22–33.
10. de Lange DW, Hijmering ML, Lorsheyd A, Scholman WL, Kraaijenhagen RJ, Akkerman JW, et al. Rapid intake of alcohol (binge drinking) inhibits platelet adhesion to fibrinogen under flow. Alcohol Clin Exp Res 2004;28:1562–8.
11. Engström M, Schött U, Reinstrup P. Ethanol impairs coagulation and fibrinolysis in whole blood: a study performed with rotational thromboelastometry. Blood Coagul Fibrinolysis 2006;17:661–5.
12. van de Wiel A, van Golde PM, Kraaijenhagen RJ, Borne von dem PA, Bouma BN, Hart HC. Acute inhibitory effect of alcohol on fibrinolysis. Eur J Clin Invest 2001;31:164–70.
13. Delahousse B, Maillot F, Gabriel I, Schellenberg F, Lamisse F, Gruel Y. Increased plasma fibrinolysis and tissue-type plasminogen activator/tissue-type plasminogen activator inhibitor ratios after ethanol withdrawal in chronic alcoholics. Blood Coagul Fibrinolysis 2000;12:59–66.
14. Erstad BL, Costa CM, Daller JA, Fortune JB. Lack of hematologic effects of recent ethanol ingestion by trauma patients. Am J Ther 1999;6:299–302.
15. Charbonney E, McFarlan A, Haas B, Gentilello L, Ahmed N. Alcohol, drugs and trauma: consequences, screening and intervention in 2009. Trauma 2009;12:5–12.
16. Plurad D, Demetriades D, Gruzinski G, Preston C, Chan L, Gaspard D, et al. Motor vehicle crashes: the association of alcohol consumption with the type and severity of injuries and outcomes. J Emerg Med 2010;38:12–7.
17. Mina AA, Knipfer JF, Park DY, Bair HA, Howells GA, Bendick PJ. Intracranial complications of preinjury anticoagulation in trauma patients with head injury. J Trauma 2002;53:668–72.
18. Vavilala MS, Dunbar PJ, Rivara FP, Lam AM. Coagulopathy predicts poor outcome following head injury in children less than 16 years of age. J Neurosurg Anesthesiol 2000;13:13–8.
19. Pories SE, Gamelli RL, Vacek P, Goodwin G, Shinozaki T, Harris F. Intoxication and injury. J Trauma 1992;32:60–4.
20. Waller PF, Stewart JR, Hansen AR, Stutts JC, Popkin CL, Rodgman EA. The potentiating effects of alcohol on driver injury. JAMA 1986;256:1461–6.
21. Bilello J, McCray V, Davis J, Jackson L, Danos LA. Acute ethanol intoxication and the trauma patient: hemodynamic pitfalls. World J Surg 2011;35:2149–53.
22. Watson PE, Watson ID, Batt RD. Prediction of blood alcohol concentrations in human subjects. Updating the Widmark Equation. J Stud Alcohol 1981;42:547–56.
23. Mitchell MC, Teigen EL, Ramchandani VA. Absorption and peak blood alcohol concentration after drinking beer, wine, or spirits. Alcohol Clin Exp Res 2014;38:1200–4.
24. Görlinger K, Jambor C, Dirkmann D, Dusse F, Hanke A, Adamzik M, et al. Platelet function analysis with point-of-care methods. Herz 2008;33:297–305.
25. Rainey PM. Relation between serum and whole-blood ethanol concentrations. Clin Chem 1993;39:2288–92.
26. Winek CL, Carfagna M. Comparison of plasma, serum, and whole blood ethanol concentrations. J Anal Toxicol 1987;11:267–8.
27. Howard BM, Kornblith LZ, Redick BJ, Conroy AS, Nelson MF, Calfee CS, et al. Exposing the bidirectional effects of alcohol on coagulation in trauma: impaired clot formation and decreased fibrinolysis in rotational thromboelastometry. J Trauma Acute Care Surg 2018;84:97–103.
28. Wohltmann CD, Franklin GA, Boaz PW, Luchette FA, Kearney PA, Richardson JD, et al. A multicenter evaluation of whether gender dimorphism affects survival after trauma. Am J Surg 2001;181:297–300.
29. Napolitano LM, Greco ME, Rodriguez A, Kufera JA, West RS, Scalea TM, et al. Gender differences in adverse outcomes after blunt trauma. J Trauma 2001;50:274–80.
30. Basista MH, Joseph A, Smolen S, Koterba A, Brecher AS. Acetaldehyde alters coagulation protein function. Dig Dis Sci 1994;39:2421–5.
31. de Gaetano G, Di Castelnuovo A, Rotondo S, Iacoviello L, Donati MB. A meta-analysis of studies on wine and beer and cardiovascular disease. Pathophysiol Haemost Thromb 2002;32:353–5.
32. Marmot MG. Alcohol and coronary heart disease. Int J Epidemiol 2001;30:724–9.
33. Kaufmann CR, Dwyer KM, Crews JD, Dols SJ, Trask AL. Usefulness of thrombelastography in assessment of trauma patient coagulation. J Trauma 1997;42:716–20.
34. Wong CA, Liu S, Glassenberg R. Comparison of thrombelastography with common coagulation tests in preeclamptic and healthy parturients. Reg Anesth 1995;20:521–7.
35. Engström M, Reinstrup P, Schött U. An in vitro evaluation of standard rotational thromboelastography in monitoring of effects of recombinant factor VIIa on coagulopathy induced by hydroxy ethyl starch. BMC Blood Disord 2005;5:3.
36. Bowbrick VA, Mikhailidis DP, Stansby G. Influence of platelet count and activity on thromboelastography parameters. Platelets 2003;14:219–24.
37. Nielsen VG. The detection of changes in heparin activity in the rabbit: a comparison of anti-xa activity, thrombelastography, activated partial thromboplastin time, and activated coagulation time. Anesth Analg 2002;95:1503–6.
38. Howard BM, Kornblith LZ, Redick BJ, Vilardi RF, Balhotra KS, Crane JM, et al. The effects of alcohol on coagulation in trauma patients: Interpreting thrombelastography with caution. J Trauma Acute Care Surg 2014;77:865–72.
39. Sauaia A, Moore FA, Moore EE, Moser KS, Brennan R, Read RA, et al. Epidemiology of trauma deaths: a reassessment. J Trauma 1995;38:185–93.
40. Brohi K, Singh J, Heron M, Coats T. Acute traumatic coagulopathy. J Trauma 2003;54:1127–30.
41. Risberg B, Medegård A, Heideman M, Gyzander E, Bundsen P, Odén M, et al. Early activation of humoral proteolytic systems in patients with multiple trauma. Crit Care Med 1986;14:917–25.
42. Enderson BL, Chen JP, Robinson R, Maull KI. Fibrinolysis in multisystem trauma patients. J Trauma 1991;31:1240–6.

Article information Continued

Fig. 1.

Point-of-care setup for our study at the department’s Christmas party.

Fig. 2.

Flow-chart of the study design. ROTEM: rotational thromboelastometry, BAC: blood alcohol concentration, BrAC: breath alcohol concentration.

Fig. 3.

Rotational thromboelastometry parameters in male. eCT: ExTEM clotting time, eA10: ExTEM amplitude 10 minutes after clotting started, eMCF: ExTEM maximum clot firmness, eCFT: ExTEM clot formation time, fCT: FibTEM clotting time, fA10: FibTEM amplitude 10 minutes after clotting started, fMCF: FibTEM maximum clot firmness. *P < 0.05, differences between baseline and 1 h.

Table 1.

Basic Patient Data and Ethanol Ingestion

All (n = 20) Male (n = 11) Female (n = 9) P value
Age (yr) 29.4 ± 6.0 32.2 ± 6.1 26.0 ± 3.9 0.013
Height (cm) 177.5 ± 8.6 181.5 ± 7.1 172.6 ± 8.0 0.019
Weight (kg) 77.7 ± 16.5 84.8 ± 18.5 69.0 ± 8.1 0.023
BMI (kg/m2) 24.6 ± 4.2 25.7 ± 5.2 23.17 ± 2.1 0.162
Ethanol (g) 51.3 ± 13.5 59.4 ± 13.0 41.4 ± 4.9 0.001
BAC after 1 h/‰ 0.8 ± 0.2 0.9 ± 0.2 0.6 ± 0.2 0.004

Values are presented as mean ± SD. BMI: body mass index, BAC: blood alcohol concentration.

Table 2.

Blood Alcohol Concentrations and Rotational Thromboelastometry Parameters (n = 20)

Baseline (n = 20)
30 min (n = 20)
1 h (n = 20)
P value* P value
BAC (‰) 0 ± 0 0.5 ± 0.3 0.8 ± 0.2 <0.001 0.002
BrAC (‰) 0 ± 0 0.6 ± 0.2 0.6 ± 0.2 <0.001 0.002
eCT (s) 61.4 ± 7.9 62.0 ± 12.2 60.2 ± 9.5 0.608 1.000
eA10 (mm) 56.4 ± 6.2 56.9 ± 6.2 55.7 ± 6.5 0.354 1.000
eMCF (mm) 62.9 ± 5.6 63.0 ± 5.2 62.1 ± 5.9 0.248 1.000
eCFT (s) 86.5 ± 19.7 83.5 ± 20.5 85.6 ± 21.0 0.768 1.000
eML (%) 0.5 ± 1.1 0.2 ± 0.5 0.1 ± 0.4 0.149 0.894
fA10 (mm) 14.0 ± 4.8 13.2 ± 4.7 13.0 ± 4.2 0.014 0.112
fMCF (mm) 16.2 ± 8.7 13.7 ± 4.6 13.7 ± 4.9 0.075 0.525
fML (%) 1.4 ± 2.0 2.2 ± 2.5 2.1 ± 2.3 0.279 1.000

Values are presented as mean ± SD. BAC: blood alcohol concentration, BrAC: breath alcohol concentration, eCT: ExTEM clotting time, eA10: ExTEM amplitude 10 minutes after clotting started, eMCF: ExTEM maximum clot firmness, eCFT: ExTEM clot formation time, eML: ExTEM maximum lysis, fCT: FibTEM clotting time, fA10: FibTEM amplitude 10 minutes after clotting started, fMCF: FibTEM maximum clot firmness, fML: FibTEM maximum lysis,


P value: significance of value differences between baseline and 1 h,

P value: significance of values after applying the Holm-Bonferroni method,

P value lower than 0.05.

Table 3.

Sex Aspects

1 h
P value* P value
Male (n = 11)
 cCT (s) 64.7 ± 5.4 63.7 ± 8.4 0.748 1.000
 eA10 (mm) 55.2 ± 5.4 53.6 ± 6.0 0.190 1.000
 eMCF (mm) 61.8 ± 5.3 60.2 ± 5.9 0.178 1.000
 eCFT (s) 90.2 ± 17.4 92.1 ± 20.2 0.688 1.000
 eML (%) 0.8 ± 1.3 0.2 ± 0.6 0.208 1.000
 fA10 (mm) 13.4 ± 4.5 11.6 ± 3.8 0.005 0.042
 fMCF (mm) 16.4 ± 10.8 12.1 ± 4.3 0.960 1.000
 fML (%) 1.7 ± 2.3 2.6 ± 2.3 0.468 1.000
Female (n = 9)
 cCT (s) 57.2 ± 8.8 55.9 ± 9.4 0.706 1.000
 eA10 (mm) 57.9 ± 7.1 58.2 ± 6.4 0.715 1.000
 eMCF (mm) 64.2 ± 6.0 64.4 ± 5.5 0.622 1.000
 eCFT (s) 82.0 ± 22.4 77.6 ± 20.1 0.320 1.000
 eML (%) 0.1 ± 0.3 0.0 ± 0.0 0.347 1.000
 fA10 (mm) 14.8 ± 5.2 14.6 ± 4.3 0.681 1.000
 fMCF (mm) 16.0 ± 5.6 15.6 ± 5.1 0.498 1.000
 fML (%) 0.9 ± 1.5 1.4 ± 2.4 0.325 1.000

Values are presented as mean ± SD. eCT: ExTEM clotting time, eA10: ExTEM amplitude 10 minutes after clotting started, eMCF: ExTEM maximum clot firmness, eCFT: ExTEM clot formation time, eML: ExTEM maximum lysis, fCT: FibTEM clotting time, fA10: FibTEM amplitude 10 minutes after clotting started, fMCF: FibTEM maximum clot firmness, fML: FibTEM maximum lysis,


P value: significance of value differences between baseline and 1 h,

P value: significance of values after applying the Holm-Bonferroni method,

P value lower than 0.05.